|

Anti-HER2 Therapy Clinical Trials

1 actively recruiting trial

Also known as: Pertuzumab, Trastuzumab, Trastuzumab Emtansine

Top Sponsors

  • Fundación Santa Fe de Bogota1

Indications

  • Triple Negative Breast Neoplasms1
  • Breast Neoplasms1
  • Hormone Receptor Positive Breast Cancer1
  • HER2-positive Breast Cancer1
  • Lung Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.